Pneumonia Testing Market to Hit USD 3.10 Bn by 2029: Competitive Landscape, Industry Analysis, New Opportunities, Dynamics and Regional Insights

April 14 20:10 2023
Pneumonia Testing Market to Hit USD 3.10 Bn by 2029: Competitive Landscape, Industry Analysis, New Opportunities, Dynamics and Regional Insights
Pneumonia Testing Market
Pneumonia Testing Market size was valued at USD 1.73 Billion in 2021 and the total Pneumonia Testing Market revenue is expected to grow at 7.35% from 2022 to 2029, reaching nearly USD 3.10 Billion.

Pune 14 April 2023: The “Pneumonia Testing Market” was USD 1.73 Bn in 2021 and is expected to grow at a CAGR of 7.35 percent to reach USD 3.10 Bn by 2029 during the forecast period. The Pneumonia Testing Market report is published by Maximize Market Research and is available in the market.                  

Pneumonia Testing Market Scope and Research Methodology 

The report is a thorough analysis of the Pneumonia Testing market provided with key findings including Pricing, investments, expansion plans, and physical presence in the Pneumonia Testing market. The bottom-up approach was used to understand the Pneumonia Testing market size estimation and growth rates in the report. The report provides information on the drivers, restraints, opportunities, and challenges of the Pneumonia Testing market. The financial standing, portfolio, technology adoption, merger and acquisition, joint ventures and strategic alliances are included in the competitive environment for the Pneumonia Testing market.

Regional analysis of the Pneumonia Testing market conducted at a local, regional and global level. The report includes primary and secondary collection techniques with qualitative and quantitative approaches for the analysis of the Pneumonia Testing market.  SWOT analysis is used to identify the threats and weaknesses of the market while PORTER is used to understand the competitive intensity of the industry in the Pneumonia Testing Market.  

Pneumonia Testing Market Dynamics  

The old-aged generation and pediatric populations have an increased susceptibility to the development of pneumonia. Pneumonia is referred to as the most common cause of hospitalization among all infectious infections disease. The increase in the elderly population increases the prevalence of Pneumonia which helps to drive the growth of the market. 

Pneumonia Testing Market is driven by the development of the advanced multiplex PCR for Pneumonia detection growing adoption of the point of care, rising advances in Pneumonia diagnosis, availability of reimbursements, the explosion of Pneumonia in children and an increase in the healthcare infrastructure. The increasing awareness about the benefits of early diagnostics among people and the introduction of advanced nucleic acid detection tests are also the growth contributor to the Pneumonia Testing Market.

During the forecast period, the market growth is restrained by the traditional way of Pneumonia Testing and consideration of the chest X-ray as a gold standard for Pneumonia diagnostics. 

Get a Sample Copy of the Report: 

Pneumonia Testing Market Regional Insights

In 2021, North America had a value of USD 225.5 Mn for the Pneumonia Testing Market and is expected to dominate the significant position over the forecast period. The regional market is driven by the increasing cases of pneumonia, innovation of the launches of technologically advanced products, growth in healthcare expenditure, increase in the availability of reimbursement and rapid adoption of point-of-care technologies.

During the forecast period, Europe is expected to dominate the market with the second-largest position. The increasing number of hospitalization, growing awareness about Pneumonia Testing among consumers,  adoption of advanced technologies in the healthcare sector,  increasing patient tools and the presence of several industry players are the factor responsible to influences the growth of the Pneumonia Testing Market.

Pneumonia Testing Market Segmentation

By Product Type

  • Analyzer segment
  • Consumable segment


By End-User

  • Diagnostic Laboratories
  • Hospitals
  • Clinics
  • Others


By Type

    • legionella-based
    • streptococcus-based
    • viral pneumonia based
  • mycoplasma based


Pneumonia Testing Market Key Players Include:

  • Thermo Fisher Scientific Inc. (US)
  • Abbott Laboratories (US)
  • Becton, Dickenson and Company (US)
  • Hologic Inc (US)
  • Bio-Rad Laboratories Inc (US)
  • Meridian Biosciences (US)
  • Quest Diagnostics (US)
  • Quidel (US)
  • Beckman Coulter Inc (US)
  • Cepheid (US)
  • Diamedix Corporation (US)
  • Luminex Corporation (US)
  • True Bearing Diagnostics, Inc. (US)
  • Curetis AG (Germany)
  • Concile GmbH (Germany)
  • QIAGEN N.V. (Germany)
  • F. Hoffmann-La Roche AG (Switzerland)
  • BioMerieux (France)
  • DiaSorin SpA (Italy)
  • Trinity Biotech (Ireland)
  • Fast Track Diagnostics (Luxembourg)
  • InTec PRODUCTS, INC (China)


Table of Content for Global Pneumonia Testing Market: 

  • Global Pneumonia Testing Market: Research Methodology


  • Global Pneumonia Testing Market: Executive Summary
  • Market Overview and Definitions
  • Introduction to Global Market  
  • Summary
  • Key Findings 
  • Recommendations for Investors
  • Recommendations for Market Leaders 
  • Recommendations for New Market Entry


  • Global Pneumonia Testing Market: Competitive Analysis
  • MMR Competition Matrix
  • Market Structure by region
  • Competitive Benchmarking of Key Players
  • Consolidation in the Market
  • M&A by region
  • Key Developments by Companies
  • Market Drivers
  • Market Restraints
  • Market Opportunities 
  • Market Challenges
  • Market Dynamics
  • PORTERS Five Forces Analysis
  • Regulatory Landscape by region
  • North America
  • Europe
  • Asia Pacific
  • Middle East and Africa
  • South America
  • COVID-19 Impact


  • Global Pneumonia Testing Market  Segmentation
  • Global Market, by Product Type (2021-2029)
  • Global Market, by  End-User (2021-2029)
  • Global Market, by Type (2021-2029)


  • Regional Pneumonia Testing Market  (2021-2029)
  • Regional Market, by Product Type (2021-2029)
  • Regional Market, by  End-User (2021-2029)
  • Regional Market, by Type (2021-2029) 
  • Regional Market, by Country (2021-2029)     


  • Company Profile: Key players
  • Company Overview
  • Financial Overview
  • Global Presence
  • Capacity Portfolio
  • Business Strategy 
  • Recent Developments


Get the Sample PDF of Report: 

Key Offerings:

  • Past Market Size and Competitive Landscape (2018 to 2021)
  • Past Pricing and price curve by region (2018 to 2021)
  • Market Size, Share, Size & Forecast by different segment | 2021−2029
  • Market Dynamics – Growth Drivers, Restraints, Opportunities, and Key Trends by Region
  • Market Segmentation – A detailed analysis of the Product  Type, End-User, Type and Region 
  • Competitive Landscape – Profiles of selected key players by region from a strategic perspective 
    • Competitive landscape – Market Leaders, Market Followers, Regional player
    • Competitive benchmarking of key players by region
  • PESTLE Analysis 
  • PORTER’s analysis 
  • Value chain and supply chain analysis 
  • Legal Aspects of Business by Region
  • Recommendations


Key questions answered in the Pneumonia Testing Market are:

  • What are Pneumonia Testing?
  • What was the Pneumonia Testing market size in 2021?
  • What is the growth rate of the Pneumonia Testing Market?
  • Which are the factors expected to drive the Pneumonia Testing market growth?
  • What are the different segments of the Pneumonia Testing Market?
  • What are the factors restraining the growth of the Pneumonia Testing Market?
  • What is the demand pattern of the Pneumonia Testing Market?
  • What major challenges could the Pneumonia Testing Market face in the future? 
  • What segments are covered in the Pneumonia Testing Market?
  • Who are the key players in the Global Pneumonia Testing market?
  • What are the upcoming industry applications and trends for the Pneumonia Testing Market?


Maximize Market Research is leading Healthcare and research firm, has also published the following reports:

Respiratory Disease Testing Market – The market size is expected to reach USD 23.39 Bn by 2029 at a CAGR of 9.20 percent during the forecast period. The market is driven by rising pollution in the environment and growing advances in technological investment and in-vitro diagnostic tests.

Sepsis Diagnostics Market – The market size is expected to reach USD 1120 Mn by 2029 at a CAGR of 7.17 percent during the forecast period. The market is driven by the development of quick diagnostic methods and point-of-care tests for sepsis and the increasing incidence of hospital-acquired infections.


About Maximize Market Research: 

Maximize Market Research is a multifaceted market research and consulting company with professionals from several industries. Some of the industries we cover include medical devices, pharmaceutical manufacturers, science and engineering, electronic components, industrial equipment, technology and communication, cars and automobiles, chemical products and substances, general merchandise, beverages, personal care, and automated systems. To mention a few, we provide market-verified industry estimations, technical trend analysis, crucial market research, strategic advice, competition analysis, production and demand analysis, and client impact studies.


Contact Maximize Market Research:

3rd Floor, Navale IT Park, Phase 2

Pune Banglore Highway, Narhe,

Pune, Maharashtra 411041, India

[email protected] 

+91 96071 95908, +91 9607365656

Media Contact
Contact Person: Geeta Yevle
Email: Send Email
Phone: +91 9607365656
Address:3rd Floor, Navale IT Park, Phase 2, Pune Banglore Highway, Narhe,
City: Pune
State: Maharashtra
Country: India